Comparative Pharmacology
Head-to-head clinical analysis: NEUPOGEN versus RYZNEUTA.
Peer-Reviewed Evidence
Head-to-head clinical analysis: NEUPOGEN versus RYZNEUTA.
NEUPOGEN vs RYZNEUTA
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Filgrastim is a human granulocyte colony-stimulating factor (G-CSF) produced by recombinant DNA technology. It acts by binding to G-CSF receptors on hematopoietic progenitor cells, stimulating proliferation, differentiation, and maturation of neutrophils.
Granulocyte colony-stimulating factor, acts on hematopoietic cells by binding to G-CSF receptors, stimulating proliferation, differentiation, and release of neutrophils.
5 mcg/kg subcutaneously or intravenously once daily for up to 14 days, or until absolute neutrophil count reaches 10,000/mm³ after nadir. For mobilization of peripheral blood progenitor cells: 10 mcg/kg subcutaneously once daily for 6-7 days.
6 mg subcutaneously once per chemotherapy cycle, administered approximately 24 hours after cytotoxic chemotherapy. Do not administer within the period from 14 days before to 24 hours after administration of cytotoxic chemotherapy.
None Documented
None Documented
3.5 hours (range 2.5–4.5 hours) in healthy subjects; terminal elimination half-life is prolonged in patients receiving chemotherapy due to decreased clearance, approximately 5.5 hours.
The terminal elimination half-life is approximately 20–30 hours in healthy volunteers and up to 40 hours in cancer patients receiving chemotherapy, reflecting FcRn-mediated recycling and delayed clearance.
Primarily renal; greater than 90% of filgrastim is eliminated via renal excretion as intact protein and degraded metabolites. Biliary/fecal excretion is minimal (<1%).
Renal clearance accounts for approximately 70% of total clearance, with the remainder via hepatic/biliary/fecal routes. Unchanged drug is minimal as efbemalenograstim alfa is a recombinant fusion protein expected to undergo catabolism to small peptides and amino acids.
Category C
Category C
Colony-Stimulating Factor
Colony-Stimulating Factor